News

Fitch Enhances Ratings for PenFed Auto Loan Securitization

Fitch Enhances Ratings for PenFed Auto Loan Securitization

Fitch Ratings Upgrades PenFed's Auto Loan Securitizations

Fitch Global Ratings has recently upgraded one class and affirmed three classes of the bonds in PenFed Auto Receivables Owner Trust 2022-A, showcasing the significant performance of these securitizations.

PenFed Credit Union, one of the largest federal credit unions in the country, has received noteworthy ratings upgrades from Fitch due to the exceptional performance of its inaugural prime auto loan securitization, PenFed Auto Receivables Owner Trust 2022-A. This upgrade is a clear signal of the strong credit quality associated with the bonds issued through this initiative.

The affirmations and upgrades of the outstanding notes are a reflection of the available credit enhancement (CE) and the historical loss performance observed to date. Notably, the cumulative net losses (CNL) have been consistently lower than the original rating case proxy, indicating a robust credit performance. Since the closing of the securitization, the hard CE levels across all classes have demonstrated considerable growth.

As reported in the March evaluation date, delinquency rates of over 60 days stand at a low 0.24% of the remaining collateral balance, with the CNL at 0.29%. This performance is notably favorable as it remains significantly below the initial rating case proxy levels. The growing hard CE of the current adjusted pool balance has been confirmed across all classes. Furthermore, Fitch has affirmed the 'AAA' rating for the A-4, B, and C tranches while upgrading the D tranche to 'AAA,' previously rated as 'AA'. This results in all outstanding tranches in this transaction now holding a 'AAA' rating.

Fitch’s careful analysis led to the maintenance of conservative assumptions in establishing the rating case proxy, thanks to the strong performance witnessed historically. The rating case proxy's conservative projection stands at 0.60%. Recognizing the current economic environment's dynamics, Fitch found it prudent to adopt a conservative stance, which has proven beneficial for the transaction.

On the other hand, the base case proxy, which is devoid of any margins for safety, saw an increase from 0.30% to 0.40%, taking into account the overarching macroeconomic conditions. The modeling of cash flow produced positive multiples exceeding 5.0x for the 'AAAs' across each class, reinforcing the strong credit standing of PenFed’s asset-backed securities.

The issuance in August 2022 saw PenFed launch $460,292,000 in fixed-rate, amortizing asset-backed notes secured by prime auto loans. These notes are part of a private placement offering, exclusively made available to qualified institutional buyers as per Rule 144A. The asset-backed notes were rated by prominent agencies like S&P and Fitch, ensuring a high level of trust and reliability in this financial product.

In terms of its standing among credit unions, PenFed proudly holds the title of having the second-largest consumer loan portfolio, spanning auto loans, personal loans, student loans, consumer loans, and credit cards. Additionally, with one of the most significant auto loan portfolios within federal credit unions, PenFed's reach extends across all 50 states and Puerto Rico.

About PenFed Credit Union
Founded in 1935, Pentagon Federal Credit Union (PenFed) is among America's largest federal credit unions, boasting nearly 3 million members globally and managing $31 billion in assets. PenFed is committed to providing market-leading financial products including certificates, checking, credit cards, personal loans, auto loans, mortgages, and much more, placing members' interests at the forefront. The credit union is insured federally by the NCUA and practices equal housing lending.

To discover more about PenFed Credit Union, visit PenFed.org, connect with us on Facebook, and follow us @PenFed on X.

Interested in building a career with PenFed? Check us out on LinkedIn. We are an Equal Employment Opportunity Employer.

Frequently Asked Questions

1. What recent upgrades did Fitch Ratings make for PenFed?

Fitch upgraded one class and affirmed three classes of bonds in PenFed's auto loan securitization as part of its regular review process.

2. What performance metrics influenced these upgrades?

The upgrades were mainly driven by low cumulative net losses and strong delinquency rates, indicating good credit quality.

3. What is the significance of the tranches' 'AAA' ratings?

The 'AAA' ratings suggest top-tier credit quality and a strong capacity to meet payment obligations, which enhances investor trust.

4. How much did PenFed issue in their 2022 securitization?

PenFed issued $460,292,000 of fixed-rate, amortizing asset-backed notes in August 2022, backed by prime auto loans.

5. Where can I find more information about PenFed?

For more information, you can visit PenFed's official website at PenFed.org.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ridero Innovates with $2.7M to Tackle Auto Finance Woes

Updated Category News Views 93

Ridero Gets Serious About Fixing Auto Financing When you've got startups like Ridero stepping up with a $2.7 million cash infusion, you can't help but sit up and listen. These folks are charging head-on into the automotive financing jumble, and they're bringing some high-tech toys to the party. With RiverPark Ventures and a slew of other big-name backers, Ridero's dialing...

Continue Reading
Gildan Faces Class Action Over Alleged Market Missteps

Updated Category News Views 64

Legal Storm Brews Over Gildan's Securities Conduct Listen, investors are no strangers to turbulence. But when a company's integrity takes a nosedive, that's when things get precarious fast. Gildan Activewear Inc. (NYSE: GIL) finds itself neck-deep in legal trouble, thanks to alleged securities law violations. On November 9, 2026, DJS Law Group got the ball rolling on a...

Continue Reading
Western Digital Faces Investigation Over Fiduciary Breaches

Updated Category News Views 42

Ringside Seat to Western Digital's Legal Turbulence If there's one thing that'll make an investor's hair stand on end, it's the whisper of fiduciary breaches. Western Digital Corporation (NASDAQ:WDC) just took a hit from Levi & Korsinsky, LLP, who've launched a full-scale investigation into potential breaches of fiduciary duties by select officers and directors. When a...

Continue Reading
Ericsson Buybacks: Strategic Moves or Market Maneuver?

Updated Category News Views 106

Breaking Down Ericsson's Strategic Share Buybacks When a company like Ericsson starts pulling stocks off the shelves like they're on sale, it's time to take notice. Between November 2nd and 6th, Ericsson, that telecom giant we all know, went on a little shopping spree, snapping up 500,000 of its own Class B shares. Why should we care? Well, it's a part of their hefty SEK...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 59

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
CD Rates on the Rise: What Savers Need to Know

Updated Category News Views 23

CD Rates: A Change in the Winds If you think of certificates of deposit (CDs) like a quiet corner booth at your local bar, you might be in for a surprise. Right now, it feels like the DJ just turned up the volume. We've seen a noteworthy 88% of rate changes heading upward lately, according to CD Valet's latest data. In numbers that speak loud and clear, the median CD rate...

Continue Reading
NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 11

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading
Paul Taubman Takes Helm at Cold Spring Harbor Lab

Updated Category News Views 217

Paul Taubman Steers the Ship at CSHL Here's the buzz coming out of Cold Spring Harbor Lab: they're handing the reins over to Paul Taubman. It's like swapping captains in the middle of the ocean—big shoes need to stay afloat. This place isn't just the playground for science nerds; it's a powerhouse in biomedical research. Now, we've got Taubman, a fella who's been...

Continue Reading
Quest Diagnostics at Jefferies Conference: What’s Next?

Updated Category News Views 54

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Continue Reading
Creality's Kid-Friendly AI 3D Printer Debuts at $329

Updated Category News Views 7

Creality Unpacks mBox for Young Innovators You squint at the market to find the next big thing, and here comes Creality tossing a fancy innovation into the ring. Meet the mBox—a kid-operated, AI-driven 3D printer. This little contraption is set to spark youthful imagination, not just buzz amongst hobbyist circles. They're rolling this out on TikTok Shop from November 9...

Continue Reading

Top 5 Most Recently Viewed Articles

Potential Legal Scrutiny for aTyr Pharma: Seeking Justice for Investors

Updated Category News Views 298

Overview of aTyr Pharma, Inc. aTyr Pharma, Inc. is a biotechnology firm devoted to advancing innovative therapies for patients with rare diseases. The company focuses on immunological and neurological disorders, working diligently to bring solutions to underserved markets. As the company navigates through the complexities of drug development, it also faces scrutiny...

Continue Reading
Signs of Needing Home Care: Key Insights from Experts

Updated Category News Views 42

Spotting the Subtle Shifts Navigating the path of aging isn't exactly a walk in the park, and families often find themselves squinting to see the subtle signs that an aging parent might need a little more than just occasional check-ins. We’re not talking dramatic meltdowns here—no, it’s about those creeping changes that sneak in like an old song you haven’t heard...

Continue Reading
UPLIZNA® Receives FDA Approval for Generalized Myasthenia Gravis

Updated Category News Views 164

UPLIZNA® Gains FDA Approval for gMG in Adults UPLIZNA is an innovative new treatment for adults battling generalized myasthenia gravis (gMG), a debilitating autoimmune disorder. This approval, granted by the U.S. Food and Drug Administration (FDA), heralds a new era for gMG patients, providing them with deep and durable control over their symptoms. The most appealing...

Continue Reading
Monster Energy Launches Refreshing Strawberry Shot Variant

Updated Category News Views 254

Monster Energy Unveils Strawberry Shot Monster Energy is thrilled to announce the introduction of Monster Energy Strawberry Shot, set to captivate fans with its unique twist on the classic OG flavor. This new version infuses the iconic energy blend with an enticing hint of strawberry, promoting an enjoyable and refreshing experience. A Fresh Take on a Classic Favorite...

Continue Reading
Cohen & Steers Quarterly Performance Insights and Future Outlook

Updated Category News Views 163

Cohen & Steers Quarterly Performance Insights Cohen & Steers, Inc. (NYSE: CNS) announced its financial outcomes for the recent quarter ending on June 30. This report sheds light on the firm’s commitment to delivering exceptional results in the investment management sector. Understanding the Second Quarter Financials The recent financial report reflects the company’s...

Continue Reading